Telehealth providers in Kentucky

Verified telehealth providers serving Kentucky

Telehealth prescribing rules in Kentucky

Kentucky's general telehealth statute, KRS 211.336, provides that a practitioner-patient relationship may commence via telehealth and that an initial in-person meeting is not required unless the provider decides one is medically necessary. KRS 311.5975 requires physicians using telehealth to obtain informed consent and protect confidentiality, and directs the Kentucky Board of Medical Licensure to adopt regulations to prevent telehealth fraud and abuse. Physicians must hold a Kentucky license (Kentucky participates in the Interstate Medical Licensure Compact). The statutes do not bar asynchronous care for non-controlled drugs. The Board of Medical Licensure's current regulations (201 KAR chapter 9) include no telehealth-specific regulation; the prescribing standards there, 201 KAR 9:260 and 9:270, cover controlled substances and buprenorphine only. Kentucky's medical rules therefore do not address whether a first non-controlled prescription may follow an asynchronous-only intake, so async_prescribing_allowed is left unknown. [2] [5] [6] [9] [13]

Compounded GLP-1 access in Kentucky

The Kentucky Board of Pharmacy's 2025 guidance, "Important Update: Compounding Semaglutide and Tirzepatide," states that in general compounding pharmacies may not compound semaglutide or tirzepatide because they are commercially available, that adding another ingredient such as B12 does not avoid the essentially-a-copy rule, that a lower price is not a valid reason, and that noncompliant compounding may lead to action by both FDA and the Board. The narrow exceptions are a documented patient-specific change that produces a significant difference for that patient, or a return of the drug to the FDA shortage list. [3] [4] [11]

Research use only sellers in Kentucky

Only Kentucky-permitted pharmacies may dispense prescription drugs to Kentucky patients. "Research use only" peptides sold for human injection are unapproved new drugs under federal law regardless of labeling, are not dispensed by a pharmacist, and fall outside Kentucky's compounding regulation. The Kentucky Food, Drug and Cosmetic Act, KRS 217.075, separately bars any person from selling, delivering, holding for sale, or giving away a new drug unless an application for it has become effective under the federal act; its investigational exemption covers only drugs intended solely for investigational use by qualified experts and labeled for investigational use only. [1] [8] [12]